Chemical Structure (Apidra 01)
Apidra Injection, Solution
Product Images NDC 0088-2500
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 27 technical images submitted to the FDA as part of the official labeling for Apidra (NDC 0088-2500). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sanofi-aventis U.s. Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1a (Apidra 02)
Figure 1b (Apidra 03)
This text appears to be a chart related to glucose levels measured in mg/dL along with the time in hours. It also mentions APDRA and REGULAR, but it's not clear what they refer to.*
Figure 1c (Apidra 04)
The text provides glucose levels in mg/dL and mentions the terms aPDRA, post and REGULAR, pre. It also contains a graph with time in hours on the x-axis and glucose levels on the y-axis. However, the text is not sufficient to provide a complete description.*
Image (Apidra 05)
Figure 2 (Apidra 06)
Figure 3 (Apidra 07)
This is a table that shows the insulin types "GLusine" and "Regular" with corresponding time intervals of 20 to 40 minutes. The text also mentions "INSULIN" at the top.*
Figure 4 (Apidra 08)
Figure (Apidra 09)
Figure (Apidra 10)
Figure (Apidra 11)
Figure (Apidra 12)
Figure (Apidra 13)
Figure (Apidra 14)
Figure (Apidra 15)
Figure (Apidra 16)
Figure (Apidra 17)
This appears to be a physical description and diagram of a pen for injecting insulin. The diagram includes a protective seal, insulin reservoir with a window, outer and inner needle cap, dosage selector button, and rubber seal. The pen also indicates that it is designed to be used with pen needles, but these are not included in the package.*
Figure (Apidra 18)
Figure (Apidra 19)
Figure (Apidra 20)
Figure (Apidra 21)
Figure (Apidra 22)
Figure (Apidra 23)
Figure (Apidra 24)
Figure (Apidra 25)
Principal Display Panel (10 mL Vial Carton)
This is a medication called Apidra® which contains insulin glulisine for injection. Each mL has 100 IU of insulin glulisine, along with other ingredients. The package insert contains information about dosage and administration. The medication should be used cautiously and only under medical supervision. An unopened Apidra® vial should be stored refrigerated and discarded after 28 days if left at room temperature. The opened vials can be kept unrefrigerated for up to 28 days. The manufacturer is sanofi-aventis U.S. LLC. The text also includes a warning to keep the medication out of reach of children, and a GTIN number.*
Principal Display Panel (3 mL Pen Carton)
This is a description of a medical product by Sanofi for insulin glulisine injection in a disposable insulin delivery device. The product comes in a sealed carton containing five 3 mL prefilled pens and is for subcutaneous injection only. It is important to use the solution only if it is clear and colorless with no visible particles, and to use within 28 days after initial use. The product does not include needles.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
